期刊文献+

Th17细胞在子痫前期患者外周血表达增加 被引量:2

Th17 cells are increased in preeclampsia patients
原文传递
导出
摘要 观察正常妊娠妇女和子痫前期疾病患者外周血CD4+T细胞中Th17细胞和特异性转录因子维A酸相关孤独受体(retinoid-related orphan nuclear receptor,RORγt)的表达和意义。实验组为子痫前期疾病患者25例,正常妊娠妇女20例,未孕妇女20例。采集研究对象外周血,酶联免疫吸附试验(ELISA)检测Th17细胞相关细胞因子IL-17A,IL-6,TNF-α的表达,Ficoll法分离外周血单个核细胞(PBMC),免疫磁珠分选CD4+T淋巴细胞,逆转录-聚合酶联反应(RT-RCR)半定量检测CD4+T细胞中Th17细胞特异性转录因子RORγt的表达,流式细胞术检测CD4+IL-17+T细胞比例。子痫前期患者外周血清中IL-6、IL-17A的含量分别为(31.72±13.34)ng/L、(2.61±1.64)ng/L,高于正常妊娠组水平,差异有显著统计学意义(P<0.01),TNF-α在子二组间的表达分别为(18.00±8.64)ng/L和(11.69±3.68)ng/L,差异有统计学意义(P<0.05);RORγt mRNA在子痫前期组的表达高于正常妊娠组,净光密度值差异有显著统计学差异(P<0.01),CD4+IL-17+T细胞在子痫前期组的表达为(1.83±0.42)%,高于正常妊娠组(0.87±0.26)%,差异有显著统计学意义(P<0.01)。子痫前期患者外周血CD4+T细胞中RORγt mRNA、Th17细胞以及Th17细胞相关细胞因子表达异常,可能在疾病的发病机理中起到重要作用。 To observe the expression of CD4+ IL-17+ T (Th17) cells and RORγt mRNA in preeclampsia patients and normal preganancy women, 25 preeclampsia patients, 20 normal pregnancy subjects and 20 non-pregnant healthy controls were included. IL-6, IL-17A and TNF-α amount in serum were measured by ELISA. CD4+T lymphocytes were separated using the magnetic BD IMag Cell Separation System according to the manufacturer's instructions. The expression of RORγt gene mRNA were detected by RT-PCR technique. The proportion of CD4+ IL-17+ T was determined by flow eytometric technique. The levels of IL-17A and IL-6 and TNF-α in preeclampsia sera were significantly higher than those in normal pregnancy, and the level of RORγt mRNA were significantly higher than that in normal pregnancy (P〈0.01). The proportion of CD4+ IL-17+ T cells in preeclampsia patients was (1.83 ± 0.42)%, stastistieally higher than that in the normal, pregnancy. (P〈0.01). Thus RORγt mRNA, Thl7 cells and Th17-related cytokines may play important roles in the pathogenesis of preeclampsia.
出处 《现代免疫学》 CAS CSCD 北大核心 2013年第2期127-130,共4页 Current Immunology
基金 江苏省南通市社会发展基金项目(S2010053) 江苏省妇幼保健重点资助项目
关键词 子痫前期 TH17细胞 RORΓT preeclampsia Th17 cell RORγt
  • 相关文献

参考文献11

  • 1Liang SC, Tan XY, Luxenberg DP, crag. tnterleukin (IL)- 22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides [J], J gxp Med. 2006,203:2271-2279.
  • 2李蓓,王敏.Th17细胞的分化与调节[J].现代免疫学,2009,29(5):431-434. 被引量:13
  • 3Manel N, Unutmaz D, Littman DR. The differentiation of human TH-I? cells requires transforming growth factor-t3 and induction of the nuclear receptor ROR'/t [J]. Nat Immunol, 2008,9 641-649.
  • 4Chen XQ, Yu YC, Deng HH, et al. Plasma IL 17A is in- creased in new-onset SLE patients and associated with disease activity[J]. J Clinlmmunol, 2010,30:221-225.
  • 5Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, et al. Interleukins 1beta and 6 but not transforming growth factor- beta are essential for the differentiation of interleukin 17-pro- ducing human T helper cells [J]. Nat Immunol, 2007,8: 942- 949.
  • 6Won HY, Sohn JH, Min H J, etal. Glutathione peroxidase 1 deficiency attenuates allergen-induced airway inflammation by suppressing Th2 and Th17 cell development [J]. Antioxid Redox Signal, 2010,13 575-587.
  • 7Madhur MS, Lob HE, McCann LA, et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction [J]. Hypertension, 2010,55:500-507.
  • 8Wong CK, Lit LC, Tam LS, etal. Hyperproduction of 11723 and IL-17 in patients with systemic lupus erythematosus: im- plications for Thl7-mediated inflammation in auto-immunity [J]. ClinImmunol, 2008,127:385-393.
  • 9Pongcharoen S, Somran J, Sritippayawan S, et al. Interleu- kin-17 expression in the human placenta [J]. Placenta, 2007, 28:59-63.
  • 10Saito S, Nakashima A, Shima T, et al. Thl/Th2/Th17 and regulatory T-cell paradigm in pregnancy [J], Am J Reprod Immunol, 2010,63:601-610.

二级参考文献21

  • 1Bettelli E, Korn T, Kuchroo VK. Th17: the third membet of the effector T cell trilogy[J]. Curr Opin Immunol, 2007,19:652-657.
  • 2Veldhoen M, Hocking RJ, Atkins C J, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells[J]. Immunity, 2006,24:179-189.
  • 3Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells[J]. Nature, 2006,441:235- 238.
  • 4GaffenSL, KramerJM, YuJJ, etal. The IL-17 cytokine family[J]. Vitam Horm, 2006,74:255-282.
  • 5Komiyama Y, Nakae S, Matsuki T, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis[J]. J Immunol, 2006,177:566-573.
  • 6Hata K, Andoh A, Shimada M, et al. IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts[J]. Am J Physiol Gastrointest Liver Physiol, 2002,282 :G1035-1044.
  • 7Reinhardt RL, Kang SJ, Liang HE, etal. T helper cell effector fates-who, how and where[J]? Curr Opin Immunol, 2006, 18:271-277.
  • 8Wraith DC, Nicolson KS, Whitley NT. Regulatory CD4^+ T cells and the control of autoimmune disease[J]. Curr Opin Immunol, 2004, 16:695-701.
  • 9Langrish CI., Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmuneinflammation[J]. J Exp Med, 2005,201:233-240.
  • 10Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17^+ T helper cells[J]. Cell, 2006, 126:1121-1133.

共引文献12

同被引文献14

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部